The global telehealth market is valued at USD 176.4 billion in 2025 and is projected to grow from USD 202.9 billion in 2026 to USD 762.69 billion by 2034, a compound annual growth rate of 18%. Contrive Datum Insights sizes these figures in its study "Telehealth Market Size, Share & Industry Analysis, 2026-2034", which covers every year from 2020 to 2034.
Telehealth here means the devices, software platforms and virtual care services that allow patients and clinicians to share health information and hold consultations from different locations. That takes in connected monitors for blood pressure, glucose and cardiac activity, the platforms that host video, audio and messaging visits, and remote monitoring programs that send device readings to a care team between appointments. Hospitals and health systems, insurers and individual subscribers all buy in.
The strongest single driver is the spread of remote patient monitoring and chronic disease management programs, which the study rates as a high-impact factor. The product lines closest to it grow quickest. Store and Forward compounds at 23.3%, lifting its share of revenue from 4% to 6% and its value from USD 7.06 billion to USD 45.76 billion. Remote Patient Monitoring is the largest product line, at 16% of 2025 revenue (USD 28.22 billion) and 22% by 2034.
The other segment cuts show a similar split between size today and speed ahead. By delivery mode, Cloud-based leads with 45% of 2025 revenue, or USD 79.38 billion. Among end users, Providers hold 48% (USD 84.67 billion) while Patients grow fastest at 19.1%. Psychiatry is the largest disease area at 22% of revenue, worth USD 38.81 billion, and Oncology grows fastest at 22.2%. Tele-consultation accounts for 52% of service revenue at USD 91.73 billion, with Tele-ICU expanding at 21.9%. Standalone Software, at 10% of 2025 revenue, grows at 16.6%, a little under the market as a whole.
Regionally, North America is the largest market, with 40% of 2025 revenue (USD 70.56 billion) and USD 274.57 billion projected for 2034. The United States alone is worth USD 59.98 billion, or 34% of the global total. Asia Pacific gains ground, moving from 28% of revenue in 2025 to 33% in 2034 as its value climbs from USD 49.39 billion to USD 251.69 billion. Middle East and Africa remains the smallest region at 4% in 2025 and 4.5% in 2034.
The forecast depends on policy as much as on technology. If reimbursement parity for virtual care is rolled back in one or more major markets, volume shifts back toward in-person visits and cloud adoption slows among smaller providers. Under that bear case, 2034 revenue reaches only USD 610.28 billion. The bull case runs the other way: parity holds and spreads to more states and national health systems, and mid-size providers finish their cloud migration early, taking 2034 revenue to USD 915.74 billion.
The study reports revenue and growth for each line across five axes: product type, delivery mode, end-use, disease area and service type. It also breaks out all five regions to country level, maps the competitive landscape and documents the method behind each estimate. The report is available as a PDF, and a free sample can be requested.